PROCEPT BioRobotics Corporation (PRCT)
NASDAQ: PRCT · Real-Time Price · USD
23.03
-1.06 (-4.40%)
At close: Apr 28, 2026, 4:00 PM EDT
23.16
+0.13 (0.56%)
After-hours: Apr 28, 2026, 5:55 PM EDT
PROCEPT BioRobotics Revenue
In the year 2025, PROCEPT BioRobotics had annual revenue of $308.05M with 37.22% growth. PROCEPT BioRobotics had revenue of $76.38M in the quarter ending December 31, 2025, with 11.94% growth.
Revenue (ttm)
$308.05M
Revenue Growth
+37.22%
P/S Ratio
4.21
Revenue / Employee
$346,908
Employees
888
Market Cap
1.30B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AdaptHealth | 3.24B |
| Enovis | 2.25B |
| CONMED | 1.37B |
| Tandem Diabetes Care | 1.01B |
| Inspire Medical Systems | 911.98M |
| Alphatec Holdings | 764.16M |
| Avanos Medical | 701.20M |
| NovoCure | 655.35M |
PRCT News
- 19 days ago - PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026 - GlobeNewsWire
- 5 weeks ago - EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH - GlobeNewsWire
- 6 weeks ago - PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy - GlobeNewsWire
- 7 weeks ago - PRCT Investors Have Opportunity to Join PROCEPT BioRobotics Corporation Fraud Investigation with the Schall Law Firm - Business Wire
- 2 months ago - PROCEPT BioRobotics Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Ademi LLP Investigates Claims of Securities Fraud against PROCEPT BioRobotics Corporation - PRNewsWire
- 2 months ago - PROCEPT BioRobotics Transcript: Investor Day 2026 - Transcripts
- 2 months ago - PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth - GlobeNewsWire